BusinessAssembly Biosciences Announces Successful Completion of ABI-H0731 Phase 1a Trial and Upcoming Conference PresentationsBy Nasdaq OMXFeb 16, 2017, 12:05 PM UTC
BusinessInsmed to Host Fourth Quarter and Year-end 2016 Financial Results Conference Call on Thursday, February 23, 2017By Nasdaq OMXFeb 16, 2017, 12:00 PM UTC
BusinessData Presented at CROI Show CytoDyn’s Pro 140 as a Single Agent Provided Maximal Virologic Suppression in HIV Patients for Nearly Two YearsBy Nasdaq OMXFeb 16, 2017, 12:00 AM UTC
BusinessTesaro to Announce Fourth-Quarter 2016 Financial Results on February 28, 2017By Nasdaq OMXFeb 14, 2017, 9:05 PM UTC
BusinessITL Pharma Receives United States Patent Protection for TriThroid® Using Sustained Drug Release and Improved Product StabilityBy Nasdaq OMXFeb 14, 2017, 2:10 PM UTC
BusinessSPLICE Agency launches to help healthcare companies speak with one voice and one mindBy Nasdaq OMXFeb 14, 2017, 1:01 PM UTC
BusinessSPLICE Agency launches to help healthcare companies speak with one voice and one mindBy Nasdaq OMXFeb 14, 2017, 1:01 PM UTC
BusinessAxsome Therapeutics Receives FDA Fast Track Designation for AXS-05 for Treatment Resistant DepressionBy Nasdaq OMXFeb 14, 2017, 12:02 PM UTC
